Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Breast Cancer Uses Growth Factors to Lure Stem Cells

08.06.2005


Like a siren song, breast cancer secretes growth factors to attract stem cells then uses those cells – which normally promote healing – to help it survive, researchers have found.



In the laboratory, the researchers have documented secretion of growth factors FGF2 and VEGF by breast cancer cells, seen these factors bind to receptors on stem cells then watched stem cells migrate toward the cancer. When they took the growth factors away, the deadly migration decreased.

“These stem cells are there to make normal tissue; they make fat, cartilage, bone,” says Dr. Adam Perry, general surgery resident at the Medical College of Georgia. “But if you have a tumor, it will in a sense mimic some tissue type to get the cells to come and help form the environment that is called the tumor stroma that it needs to get beyond a certain size. That’s really when cancer becomes clinically problematic.”


Knowing how tumors attract the stem cells they need to thrive opens up new avenues for earlier detection, better staging and more targeted therapies, he says.

Dr. Perry’s work on this fatal attraction between cancer and adult bone marrow stem cells earned him the Peter J. Gingrass, M.D. Memorial Award for the best paper presented by a medical student or non-plastic surgery resident during the recent 50th anniversary meeting of the Plastic Surgery Research Council.

“When you have a growing tumor, the tumor cells cannot stand alone,” says Dr. Edmond Ritter, MCG plastic surgeon and senior co-investigator. “Tumors have specific colon cancer or breast cancer or melanoma cells, but they also have to have supporting framework which includes fibroblasts as well as blood vessels.”

Normally, FGF2 makes connective tissue and VEGF makes blood vessels. It was known that tumors contain these growth factors as well as others and that they utilize stem cells to help build the infrastructure they need. “We wanted to figure out what attracts these stem cells,” says Dr. Perry. “What makes them move?”

“You need blood vessels. You need other tissue that forms basically a home or a nest for the tumor,” says Dr. Erhard Bieberich, MCG biochemist and senior investigator. “Without that, you don’t get metastasis. Without the activity of those stem cells, metastasis would only grow to a particular size but it would not be life-threatening. But once the body response kicks in and accepts the metastasis as some sort of useful tissue, it really gets dangerous.”

The MCG researchers hypothesized that growth factors secreted by tumors cells might play a role in this acceptance.

Dr. Bao-Ling Adam, a cancer researcher and proteomics expert, helped measure levels of FGF2 and VEGF – both proteins – using a high-tech approach that enables evaluation of hundreds of proteins at one time.

Cells need protein to survive and cells normally keep some proteins they make and shed others, Dr. Adam says. Much as a blood test can show what proteins are being secreted in the body, the researchers looked in the cell culture media where the cancer cells resided to see what proteins were being secreted.

“We wanted to see what kind of molecules are released in the media and then what molecules attract stem cells,” says Dr. Adam. They are still working to identify other molecules that were secreted, but FGF2 and VEGF were definite standouts.

“In the case of breast cancer, FGF2 and VEGF meet the criteria as candidate molecules and we believe they have an important role but are not the only answer as to why stem cells migrate,” says Dr. Ritter, who specializes in reconstruction following mastectomy.

The researchers say different kinds of tumors likely send out different growth factors to lure stem cells. In fact, they’ve already shown that melanoma also uses VEGF but not FGF2. “You don’t want to treat every tumor alike,” says Dr. Ritter.

They believe knowing the factors that help lead stem cells astray is an important first step in stopping the deadly attraction. “The first generation of chemotherapy was more targeting the cell division of cancer,” says Dr. Bieberich. “Now we are entering a new phase where we are targeting more the communication pathways.” Possibilities include using antibodies or other small molecules to block growth factor receptors or even turning the tables on cancer by arming stem cells with a mechanism to kill the cancer once they connect, he says.

Dr. Perry has seen the need for options other than chemotherapy, radiation therapy or surgery in his relatively short professional life. “What we are doing now is looking at more precise, specific ways to treat cancer on cellular level. This requires an immense understanding of tumor biology and what is going on. We are trying to chip away at that puzzle.”

Dr. Perry is just completing a year of research in the laboratories of Drs. Bieberich and Adam. He plans to pursue a plastic surgery fellowship after completing his surgery residency.

A significant part of the initial work for these studies was conducted by Kathryn Tucciarone, who worked as a research assistant in Dr. Bieberich’s lab. Dr. Jack Yu, chief of the Section of Plastic and Reconstructive Surgery, and Dr. Thomas N. Wang, surgical oncologist, also supported the studies.

Toni Baker | EurekAlert!
Further information:
http://www.mcg.edu

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>